CapsoVision Inc (CV)

CapsoVision Reports First Quarter 2026 Financial Results

SARATOGA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical...

CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026

SARATOGA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage...

CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results

SARATOGA, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage...

CapsoVision Announces $14 Million Private Placement Financing

SARATOGA, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (the “Company”) (NASDAQ: CV), a...

CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026

SARATOGA, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage...

CapsoVision to Participate in the 38th Annual ROTH Conference

- Company to participate in a fireside chat and 1x1 investor meetings on March 23, 2026 - SARATOGA, Calif...

CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus®

SARATOGA, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage...

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference

SARATOGA, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage...

CapsoVision Reports Third Quarter 2025 Financial Results

SARATOGA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage...

CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening Capsule

SARATOGA, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage...

CapsoVision Appoints David Garcia as Senior Vice President of Finance

SARATOGA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage...

CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025

SARATOGA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage...

CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

SARATOGA, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]